|
|
|
Insider
Information: |
Barrett Peter |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
4,667,117 |
|
Indirect Shares
|
23,288,256 |
|
|
Direct
Value |
$7,925,114 |
|
|
Indirect Value
|
$8,031,536 |
|
|
Total
Shares |
27,955,373 |
|
|
Total
Value |
$15,956,650 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
Percentage
Gain/Loss : |
0.0%
|
40.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alnylam Pharmaceuticals Inc |
ALNY |
Director |
2005-09-29 |
189 |
2006-03-07 |
5,293 |
Premium* |
|
Momenta Pharmaceuticals Inc |
MNTA |
Director, 10% Owner |
2004-06-21 |
0 |
2005-08-03 |
379 |
Premium* |
|
Helicos Biosciences Corp |
HLCSQ |
Director, 10% Owner |
2007-05-30 |
0 |
2009-09-18 |
11,851,387 |
Premium* |
|
Sciclone Pharmaceuticals Inc |
SCLN |
Director |
|
0 |
2011-04-18 |
1,972,189 |
Premium* |
|
Perkinelmer Inc |
PKI |
|
2024-05-01 |
23,601 |
2012-05-01 |
0 |
Premium* |
|
Larimar Therapeutics Inc |
LRMR |
Director, 10% Owner |
2016-01-25 |
4,643,327 |
2014-06-24 |
5,632,730 |
Premium* |
|
Vitae Pharmaceuticals, Inc |
VTAE |
Director |
2014-09-29 |
0 |
2014-09-29 |
1,174,315 |
Premium* |
|
Synlogic Inc |
SYBX |
Director |
|
0 |
2017-08-28 |
2,651,963 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2004-06-03 |
4 |
A |
$0.00 |
$0 |
I/I |
1,783,692 |
21,084 |
|
- |
|
PKI |
Perkinelmer Inc |
|
|
2023-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,738 |
21,406 |
0 |
- |
|
PKI |
Perkinelmer Inc |
Director |
|
2018-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,429 |
21,629 |
0 |
- |
|
PKI |
Perkinelmer Inc |
Director |
|
2019-02-13 |
4 |
S |
$93.62 |
$524,371 |
D/D |
(5,601) |
21,629 |
0 |
- |
|
PKI |
Perkinelmer Inc |
Director |
|
2020-05-28 |
4 |
S |
$100.11 |
$756,038 |
D/D |
(7,552) |
22,001 |
0 |
% |
|
PKI |
Perkinelmer Inc |
Director |
|
2019-11-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
955 |
22,502 |
0 |
- |
|
PKI |
Perkinelmer Inc |
Director |
|
2021-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,313 |
23,314 |
0 |
- |
|
PKI |
Perkinelmer Inc |
Director |
|
2019-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,828 |
23,457 |
0 |
- |
|
PKI |
Perkinelmer Inc |
|
|
2024-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,195 |
23,601 |
0 |
- |
|
PKI |
Perkinelmer Inc |
Director |
|
2020-05-08 |
4 |
A |
$0.00 |
$27,476 |
D/D |
2,301 |
24,803 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Director |
|
2005-08-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(582,810) |
25,725 |
|
- |
|
PKI |
Perkinelmer Inc |
Director |
|
2017-11-13 |
4 |
OE |
$27.79 |
$196,468 |
D/D |
7,071 |
26,271 |
0 |
- |
|
PKI |
Perkinelmer Inc |
Director |
|
2019-02-13 |
4 |
OE |
$30.51 |
$170,887 |
D/D |
5,601 |
27,630 |
0 |
- |
|
PKI |
Perkinelmer Inc |
Director |
|
2017-06-01 |
4 |
OE |
$26.15 |
$261,450 |
D/D |
10,000 |
29,200 |
0 |
- |
|
PKI |
Perkinelmer Inc |
Director |
|
2020-05-28 |
4 |
OE |
$42.09 |
$199,904 |
D/D |
4,750 |
29,552 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Director |
|
2005-07-05 |
4 |
D |
$0.00 |
$0 |
I/I |
(760,477) |
31,862 |
|
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Director |
|
2004-06-25 |
4 |
A |
$0.00 |
$0 |
I/I |
3,680,387 |
39,827 |
|
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2004-06-01 |
4/A |
B |
$6.00 |
$763,668 |
I/I |
127,278 |
127,278 |
2.25 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2004-06-01 |
4 |
B |
$6.00 |
$766,602 |
I/I |
127,767 |
127,767 |
2.25 |
- |
|
VTAE |
Vitae Pharmaceuticals, In... |
Director |
|
2014-09-29 |
4 |
A |
$0.00 |
$0 |
I/I |
1,136,815 |
1,136,815 |
0 |
- |
|
VTAE |
Vitae Pharmaceuticals, In... |
Director |
|
2014-09-29 |
4 |
B |
$8.00 |
$300,000 |
I/I |
37,500 |
1,174,315 |
2.1 |
- |
|
SCLN |
Sciclone Pharmaceuticals ... |
Director |
|
2011-04-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,972,189 |
|
- |
|
SYBX |
Synlogic Inc |
Director |
|
2017-08-28 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,651,963 |
|
- |
|
HLCSQ |
Helicos Biosciences Corp |
Director |
|
2007-05-30 |
4 |
A |
$0.00 |
$0 |
I/I |
2,654,433 |
2,654,433 |
0 |
- |
|
HLCSQ |
Helicos Biosciences Corp |
Director |
|
2007-05-30 |
4 |
B |
$9.00 |
$2,999,997 |
I/I |
333,333 |
2,987,766 |
2.25 |
- |
|
55 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|